In recent years, many efforts have been undertaken to establish new methods for DST to be used on a routine level. The epidemiology of drug-resistant and MDR-TB has posed an enormous need for faster ...
Drug susceptibility testing (DST) in Mycobacterium tuberculosis remains the cornerstone of effective tuberculosis control, guiding the choice of therapy and informing public health strategies to ...
The US Food and Drug Administration (FDA) on Wednesday launched a new website aimed at improving access to information that can help healthcare professionals determine which drugs are most likely to ...
Biomarkers to predict the efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer with actionable genetic alterations. This is an ASCO Meeting Abstract from the 2023 ASCO ...
Investigators at the Israel Institute for Biological Research have developed a rapid AST that can be performed directly on blood and environmental soil samples. 2,3 In a recent study, the ...
A new method for identifying the pathogens involved in sepsis cases, which could help to select optimal therapeutics, is reported in Nature. The test has the potential to reduce the turnaround times ...
Viable bacteria in the blood, i.e., bacteremia, can lead to bloodstream infection (BSI) and sepsis, a syndromic, often fatal, inflammatory response. Rapid and accurate antimicrobial prescriptions are ...
April 10 (UPI) --The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial intelligence, when developing monoclonal antibody therapies and ...
For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected in at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results